Jeffrey W. Moses
Lenox Hill Heart and Vascular Institute & Cardiovascular Research Foundation
New York
New York 10021
USA
Name/email consistency: high
- Brachytherapy and drug-eluting stents. Moses, J.W. J. Invasive. Cardiol (2003)
- Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. Moses, J.W., Leon, M.B., Popma, J.J., Fitzgerald, P.J., Holmes, D.R., O'Shaughnessy, C., Caputo, R.P., Kereiakes, D.J., Williams, D.O., Teirstein, P.S., Jaeger, J.L., Kuntz, R.E. N. Engl. J. Med. (2003)
- Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (subanalysis of the GAMMA I Randomized Trial). Moses, J.W., Moussa, I., Leon, M.B., Teirstein, P.S., Fish, R.D., Ellis, S.G., Nawas, D., Kluck, B., Giorgianni, J.A., Donohoe, D., Kuntz, R.E. Am. J. Cardiol. (2002)
- Perspectives of drug-eluting stents: the next revolution. Moses, J.W., Kipshidze, N., Leon, M.B. Am. J. Cardiovasc. Drugs (2002)